Бронхиальная астма: как улучшить отдаленныерезультаты лечения?

1. Global Initiative for Аsthma. NHLB/WHO Workshop Report. National Heart Lung Blood Institute, Publication number 02–3659, revised 2006. Пер. с англ. М.: Атмосфера, 2007.
2. Contoli M, Bousquet J, Fabbfi LM et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 65 (7): 141–51.
3. Weibel ER. Morphometry of the Ниmаn lung. New York: Асаdemic Press, 1963.
4. Van Brabant H, Cauberghs M, Verbeken E et al. Partitioning of pulmonary impedance in excised human and canine lungs. J Appl Physiol 1983; 55: 1733–42.
5. Wagner EM, Lui MC, Wainmann GG et al. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141: 584–8.
6. Hamid Q, Song Y, Kotsimbos TC et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44–51.
7. Саrrоll N, Cooke C, James А. The distribution of eosinophils аnd lymphocytes in the large аnd small alrways of asthmatics. Еur Respir J 1997; 10: 292–300.
8. Haley KJ, Sunday ME, Wiggs BR et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998; 158: 565–72.
9. Saetta M, Di Stefano A, Rosina C et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138–43.
10. Kraft М, Djukanovic R, Wilson S et al. Аlvеоlаr tissue inflammation in asthma. Аm J Resp Crit Care Меd 1996; 154: 1505–10.
11. Christodoulopoulos Р, Leuпg DY, Еlliot MW et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Сlin Immunol 2000; 146: 479–84.
12. Wenzel SЕ, Szefler SJ, Leung DY et al. Bronchoscopic evaluation of severe asthma. Persistent inflammafion associated with high-dose glucocorticoids. Аm J Respir Crit Саre Меd 1997; 156: 737–43.
13. Tashkin DP. The role of small airway inflammation in asthma. Allergy Asthma Proc 2002; 23 (4): 233–42.
14. Bateman ED, Boushey HA, Bousquet J et al. GOAL Investigators Group.Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170 (8): 836–44.
15. Gelfand E, Kraft M. The importance and features of the distal airways in children and adults. J Allergy Clin Immunol 2009; 124 (suppl.): S84–7.
16. Busse WW, Brazinsky S, Jacobson К et al. Еffiсасy гesроnsе оf inhaled beclomethasone dipropionate in asthma is proportional to dose аnd is improved bу formulаtion with а new ргореllant. J Allergy Clin Immunol 1999; 104: 1215–22.
17. Kraft M. Part III: Location of asthma inflammation and the distal airways: clinical implications. Curr Med Res Opin 2007; 23 (suppl. 3): S21–7.
18. Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther 2007; 20 (3): 290–303.
19. Bousquet J, Cantini L.Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite). Respir Med 2002; 96 (Suppl. D): S17–27.
20. Farmer IS, Middle M, Savic J et al. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma. Respir Med 2000; 94 (1): 57–63.
21. Fireman P, Prenner BM, Vincken W et al. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Ann Allergy Asthma Immunol 2001; 86 (5): 557–65.
22. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002; 109 (2 Suppl.): S447–60.
23. Dhillon S, Keating GM. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs 2006; 66 (11): 1475–83.
24. Huchon G, Magnussen H, Chuchalin A et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 2009; 103 (1): 41–9.
25. Ohbayashi H. One-year evaluation of the preventative effect of hydrofluoralkane-beclomethasone dipropionate on eosiphilic inflammation of asthmatic peripheral airways. Respiration 2007; 74: 146–53.
26. Vos WV, Devolder AD, Debacke LD et al. Long-term effects of combined extra-fine beclomethasone (BECL) and formoterol (FORM) treatment in asthma patients. Eur Respir J 2009; 34: S53.
27. Papi A, Paggiaro PL, Nicolini G et al. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007; 29 (4): 682–9.
28. Papi A, Paggiaro P, Nicolini G et al. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62 (10): 1182–8.